Tag: AMPECT

Home / AMPECT

Categories

Sirolimus protein-bound particles is approved for malignant perivascular epithelioid cell tumor

Jan 2022: For adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumours, the Food and Drug Administration licenced sirolimus protein-bound partic...
ampect

Scan the code